Your session is about to expire
← Back to Search
Ultrasound Technology for Detecting Lipohypertrophy in Diabetes
Study Summary
This trial is testing if a new ultrasound technology can detect early signs of lipohypertrophy, and if injecting insulin into these areas affects how insulin is absorbed.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had a skin condition in areas where insulin is usually injected.You have a diagnosis of Type 1 or Type 2 diabetes mellitus.You are currently taking medication called glucagon-like peptide-1 agonist or systemic glucocorticoid.
- Group 1: LH Protocol
- Group 2: Normal Protocol
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any more slots available for participating in this clinical experiment?
"According to data hosted on clinicaltrials.gov, this medical study is not currently accepting applicants. The trial first appeared on January 1st 2023 and was last updated October 31st 2022, though there are 1175 other trials actively seeking patients at the time of writing."
Are participants aged 75 and above welcome to join this medical experiment?
"This research study is only open for patients aged 19 to 80. Conversely, there are 185 trials targeting minors and 878 studies dedicated to adults above 65 years of age."
What types of individuals are the ideal candidates for this experiment?
"This research study seeks 100 participants aged between 19 and 80, diagnosed with diabetes mellitus. Eligible candidates must currently be undergoing a regimen of insulin injection or pump therapy for at least 2 years."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger